Case-Based Roundtable Meetings Spotlight: August 2022

Roundtable Discussion: Barriers to CAR T-Cell Therapy for DLBCL Lead to Debate About Targeted Therapy

August 27, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Pallawi Torka, MD, discussed with participants when to consider a patient for chimeric antigen receptor T-cell therapy and what alternative treatments to use for a patient with relapsed/refractory diffuse large B-cell lymphoma.

Couriel Assesses the Available Data for Treatment of Acute GVHD

August 26, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Daniel R. Couriel, MD, MS, MBA, discussed how to predict risk of acute graft-vs-host-disease and manage its effects on patients with hematologic malignancies.

Hutson Walks Through Updates in the Management of Clear Cell RCC

August 23, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Thomas Hutson, DO, PharmD, discussed the most recent data supporting immune checkpoint inhibitor plus tyrosine kinase inhibitor combinations for frontline treatment of patients with renal cell carcinoma.

Examining Treatment Options for Second-Line ES-SCLC Therapy

August 19, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Rafael Santana-Davila, MD, discussed the data supporting the use of immunotherapy for patients with extensive-stage small cell lung cancer.